ETRA
ETRA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
4
$47.21M
Insider Sales
0
$0
Total Volume
$47.21M
4 transactions
Net Activity
+$47.21M
Net buying
Sentiment Rating
Strong AccumulationCEO Conviction Index
No Recent Signal
Key Drivers
- •Strong buying bias: purchases represent 100% of total transaction value.
- •Minor cluster buying: 2 unique insiders purchased shares.
- •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Gordon Carl L
Dir, 10%
$23.61M total
Orbimed Advisors LLC
Dir, 10%
$23.61M total
Quick Actions
ETRA has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. ETRA ranks #160 in insider activity out of 569 tracked companies in its industry.
Over the last 90 days, corporate insiders at ETRA (ETRA) engaged in a total of 4 transactions reported via SEC Form 4 filings. Among these, 4 were open-market purchases and 0 were sales. The total volume of insider trading reached $47.21M.
The net insider activity for ETRA shows a net buying bias of $47.21M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Purchase by Gordon Carl L (Dir, 10%), who traded 1.33M shares valued at $20.00M on Sep 21, 2026.
Electra Therapeutics: A Broken IPO Leaves The SIRP Platform Nearly Free (NASDAQ:ETRA)
symbol__ Stock Quote Price and Forecast
Electra Therapeutics, Inc. (ETRA) Stock Price Prediction for 2026, 2030-2040
Electra Therapeutics (ETRA) director Orbimed Advisors bought 92,116 shares for $745K at an average $8.08
Two reporting persons share voting power over 3.37M Electra Therapeutics (ETRA) shares.
ETRA: Electra Therapeautics Latest Stock Price, Analysis, News and Trading Ideas
FAQs About ETRA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for ETRA.